Clinical Trials
Braintumor Website

There are 10 trials:
Facility: Institut Curie
NCT Trial Name# of Centers

NCT01303497

  Efficacity of Weekly Paclitaxel in Association or Not With Bevacizumab in Metastatic or Locally Advanced Angiosarcomas
19

NCT01414933

  High Throughput Technologies to Drive Breast Cancer Patients to Specific Phase I/II Trials of Targeted Agents
18

NCT01710605

  Medico-economic Interest of Taking Into Account Circulating Tumor Cells (CTC) to Determine the Kind of First Line Treatment for Metastatic, Hormone-receptors Positive, Breast Cancers
17

NCT01386580

  An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.
10

NCT01165333

  Cilengitide in Combination With Irradiation in Children With Diffuse Intrinsic Pontine Glioma
9

NCT01349842

  Circulating Tumor Cells to Guide Chemotherapy for Metastatic Breast Cancer
7

NCT02115074

  Safety of Fluvastatin-Celebrex Association in Low-grade and High Grade Optico-chiasmatic Gliomas
6

NCT01332929

  Safety Evaluation of a Combination of Brain Radiation Therapy and Bevacizumab (AvastinĀ®) for Treatment of Brain Metastasis
4

NCT00905281

  Study of Impact of Routine "Clinical Cancer Department/Supportive Care Department" Consultation on the Prescription of an Additional Line of Chemotherapy
2

NCT02546453

  Use of Specific Genetic Alteration s of Tumoral Cells Identified by the Next Generation Sequencing Techniques (NGS) to Follow Peripheral Samples of Children With Metastatic and/or High Risk Solid Tumor - NGSKids
1



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites